stockrowAbsci Corporation (ABSI) vs Stoke Therapeutics, Inc. (STOK)
- Absci Corporation ABSI 10.17 +8.31%
- Stoke Therapeutics, Inc. STOK 26.54 +1.80%
Absci Corporation and Stoke Therapeutics, Inc. are both Biotechnology companies. Absci Corporation and Stoke Therapeutics, Inc. are of similar size ($1.7B and $1.6B). Absci Corporation grew revenue faster over the last twelve months: −62.3% against −86.3%. Stoke Therapeutics, Inc. has the higher net margin (−862.1% vs −7,756.4%) and the lower return on invested capital (−482.0% vs −174.7%). Across the 16 metrics below, Absci Corporation leads on 8 and Stoke Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | ABSI | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (8,084.50%) | (913.12%) | 0.00% |
| Net margin | (7,756.37%) | (862.07%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (764.66%) | 0.00% |
| Return on equity | (57.72%) | (73.62%) | (51.96%) |
| Return on assets | (50.57%) | (63.42%) | (46.06%) |
| Return on invested capital | (174.74%) | (482.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack